Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2015

Dec 8, 2015

34576_dirs_2015-12-07_d0880190-a10c-439e-8ef8-c5e6105da799.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-12-04

Reporting Person: Rosenkranz Roberto Pedro (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-04 Common Stock M 4000 $2.90 Acquired 39000 Direct
2015-12-04 Common Stock M 3000 $5.95 Acquired 42000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-04 Stock Option (Right to Buy) $2.90 M 4000 Disposed 2020-04-27 Common Stock (4000) Direct
2015-12-04 Stock Option (Right to Buy) $5.95 M 3000 Disposed 2022-06-27 Common Stock (3000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 40 Indirect

Footnotes

F1: Fully vested.